AR019703A1 - NEUROPROTECTOR COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF NERVOUS ALTERATIONS AND BEHAVIOR DUE TO STATES OF ANXIETY OR DEPRESSION - Google Patents
NEUROPROTECTOR COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF NERVOUS ALTERATIONS AND BEHAVIOR DUE TO STATES OF ANXIETY OR DEPRESSIONInfo
- Publication number
- AR019703A1 AR019703A1 ARP990103007A AR019703A1 AR 019703 A1 AR019703 A1 AR 019703A1 AR P990103007 A ARP990103007 A AR P990103007A AR 019703 A1 AR019703 A1 AR 019703A1
- Authority
- AR
- Argentina
- Prior art keywords
- anxiety
- nervous
- prevention
- composition
- depression
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title abstract 2
- 230000004075 alteration Effects 0.000 title abstract 2
- 230000036506 anxiety Effects 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000001067 neuroprotector Effects 0.000 title 1
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003542 behavioural effect Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 abstract 1
- 229940005608 hypericin Drugs 0.000 abstract 1
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 abstract 1
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe una composicion para la prevencion y/o tratamiento terapéutico de alteraciones nerviosas y del comportamiento debidas a estados de ansiedad odepresion que tienen la forma de un suplemento dietético, un soporte dietético o de un medicamento, que comprende como ingredientes activos caracterizantesacetil L-carnitina e hipericina.A composition for the prevention and / or therapeutic treatment of nervous and behavioral alterations due to anxiety or depression states that have the form of a dietary supplement, a dietary support or a medicament, comprising as active active ingredients acetyl L-carnitine is described. and hypericin.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRN980425 | 1998-06-25 | ||
| IT98RM000425A IT1299195B1 (en) | 1998-06-25 | 1998-06-25 | COMPOSITION WITH NEUROPROTECTIVE ACTIVITY FOR THE PREVENTION AND TREATMENT OF STATE-RELATED NERVOUS AND BEHAVIORAL ALTERATIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR019703A1 true AR019703A1 (en) | 2002-03-13 |
Family
ID=45569883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990103007 AR019703A1 (en) | 1998-06-25 | 1999-06-23 | NEUROPROTECTOR COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF NERVOUS ALTERATIONS AND BEHAVIOR DUE TO STATES OF ANXIETY OR DEPRESSION |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR019703A1 (en) |
-
1999
- 1999-06-23 AR ARP990103007 patent/AR019703A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9909903A (en) | Maximum effectiveness of substances used to improve health and well-being | |
| AR022076A1 (en) | ANTIOXIDANT COMPOSITION CONSTITUTED BY L-CARNITINE OIL AND ALPHA-LIPOIC ACID TO IMPROVE METABOLIC USE OF GLUCOSE | |
| AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| BR9715022A (en) | Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations | |
| AR054139A1 (en) | MODIFIED FORMATION AND IMMEDIATE RELEASE OF MEMANTINE SPHERES | |
| AR025111A1 (en) | METHODS AND COMPOSITIONS TO TREAT GENERALIZED ANXIETY DISORDERS | |
| AR049955A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS | |
| AR077573A2 (en) | USE OF A TNF INHIBITOR AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT | |
| BRPI0414876A (en) | pharmaceutical compounds and compositions for the prevention of overdose or abuse and their uses | |
| DE60322436D1 (en) | ADMINISTRATION OF CAPSAICINOIDS | |
| AR044007A1 (en) | METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE | |
| ATE456369T1 (en) | FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES | |
| PT1411938E (en) | USE OF CYCLOPAMINE FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF PSORIASIS | |
| AR048833A1 (en) | PROCEDURE FOR THE TREATMENT OF PREMENSTRUAL DISORDERS AND OTHER FEMALE SEXUAL DISORDERS | |
| BR0309837A (en) | Trans-epicutaneous administration form for the treatment of restless leg syndrome | |
| AR028959A1 (en) | USE OF RAPAMYCIN FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT CARDIOVASCULAR DISEASES | |
| AR049518A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A SILICONE AGENT AND TWO SOLUBILIZED ACTIVE PRINCIPLES | |
| BR0209327A (en) | Composition for treatment of drug-induced constipation | |
| AR023391A1 (en) | COMPOSITION CONTAINING CARNITINE AND INOSITOL PHOSPHATE, USEFUL AS A DIETARY SUPPLEMENT OR DRUG | |
| ES2195939T3 (en) | COMPOSITION FOR PREVENTION AND / OR TREATMENT OF CIRCULATORY DISORDERS THAT INCLUDES DERIVATIVES OF L-CARNITINE AND GINKGO BILOBA EXTRACTS. | |
| BR0310061A (en) | Methods for treating respiratory diseases and conditions with a selective inhibitor of inos and a inhibitor of pde and their compositions | |
| AR040737A1 (en) | ORAL CALCITONINE ADMINISTRATION | |
| AR048806A1 (en) | USE OF CARIOFILENES IN THE PREPARATION OF MEDICINES AND TREATMENT OF BODY INFLAMMATION AND INFLAMMATORY PAIN AFFECTIONS | |
| BRPI0410251A (en) | melanogenesis promoter, and, melanogenesis promoter composition | |
| AR052152A1 (en) | PHARMACEUTICAL PRODUCT FOR THE PREVENTIVE AND THERAPEUTIC TREATMENT OF SUENO DISORDERS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |